MoneyWorks4Me

Alembic Pharmaceuticals completes ANVISA GMP audit for API-II Facility in Panelav

11 Dec 2024 Evaluate

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facilty at Panelav for its 8 APIs. The inspection was conducted from September 16, 2024 to September 20, 2024.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.


Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..